Tofidence Interactions
There are 433 drugs known to interact with Tofidence (tocilizumab), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 365 are moderate, and 8 are minor.
- View all 433 medications that may interact with Tofidence
- View Tofidence alcohol/food interactions (1)
- View Tofidence disease interactions (8)
Most frequently checked interactions
View interaction reports for Tofidence (tocilizumab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
Tofidence alcohol/food interactions
There is 1 alcohol/food interaction with Tofidence (tocilizumab).
Tofidence disease interactions
There are 8 disease interactions with Tofidence (tocilizumab) which include:
- infections
- tuberculosis
- demyelinating disorders
- gastrointestinal perforation
- lipid abnormalities
- liver dysfunction
- neutropenia/thrombocytopenia
- renal impairment
Report options
More about Tofidence (tocilizumab)
- Tofidence consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Plaquenil
Plaquenil is used to treat or prevent malaria and to treat the symptoms of rheumatoid arthritis ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Orencia
Orencia is a type of biologic that is given by intravenous infusion or subcutaneous injection which ...
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Leflunomide
Leflunomide is used for psoriatic arthritis, rheumatoid arthritis
Sulfasalazine
Sulfasalazine is used to treat ulcerative colitis, rheumatoid arthritis, and polyarticular-course ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
